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Edited by Ulrike KutayAbstract The adrenal gland protein AD-004 like protein
(ADLP) from Caenorhabditis elegans was cloned and expressed
in Escherichia coli. Enzyme assays showed that ADLP has spe-
cial adenylate kinase (AK) properties, with ATP and dATP as
the preferred phosphate donors. In contrast to all other AK iso-
forms, AMP and dAMP were the preferred substrates of ADLP;
CMP, TMP and shikimate acid were also good substrates. Sub-
cellular localization studies showed a predominant nuclear local-
ization for this protein, which is diﬀerent from AK1–AK5, but
similar to that of human AK6. These results suggest that ADLP
is more likely a member of the AK6 family. Furthermore, RNAi
experiments targeting ADLP were conducted and showed that
RNAi treatment resulted in the suppression of worm growth.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Adenylate kinase (AK) (EC 2.7.4.3) is a nucleoside mono-
phosphate kinase (NMPK) that catalyzes a reversible
phosphotransferase between nucleoside triphosphates and
monophosphates. It plays an important role in cell metabo-
lism, including the synthesis of DNA and RNA molecules
[1]. Adenylate kinases can also phosphorylate nucleoside ana-
logs used in the treatment of cancer and viral infection [1–7]. In
mammalian tissues, ﬁve isozymes of AK, AK1 to AK5, have
been identiﬁed [8,9]. Recently, a new AK isoform that has a
diﬀerent subcellular localization, AK6, has been identiﬁed
and characterized by crystal structure determination and enzy-
matic assays [9].
Adrenal gland protein AD-004 like protein (ADLP) from
Caenorhabditis elegans (C. elegans) is a functionally unknown
protein containing 182 amino acids. A Walker motif with con-
served sequence Gly-X-X-Gly-X-Gly-Lys in its N-terminal re-
gion was found [10] that encodes the phosphate-binding loop
and is one of the characteristics of ATPases and NMPKs
(Fig. 1A). This suggested that ADLP might possess ATPase
activity, adenylate kinase activity, or both. Furthermore, the
sequence alignment indicated that ADLP shares about 40%*Corresponding author. Fax: +86 10 62765913.
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doi:10.1016/j.febslet.2006.05.074homology with the newly identiﬁed human AK6 (Fig. 1B),
though the sequence similarity with other AKs (AK1–AK5)
is lower than 20%. This promoted us to determine whether
ADLP from C. elegans possesses features that resemble human
AK6 and belong to this novel AK isoform family. So far, in C.
elegans, only C.AK1 was found according to the NCBI anno-
tation, but no further information relating to C.AK1 has been
reported [11].
In this paper, we report the cloning and characterization of
AD-004 like protein from C. elegans. Enzymatic activity assays
and subcellular localization of this protein demonstrate that it
is a novel adenylate kinase in C. elegans, and is similar to hu-
man AK6. Result from RNA interference (RNAi) experiments
suggest that this protein may play important role in worm
growth.2. Materials and methods
2.1. Cloning and expression of C. elegans ADLP
Total RNA was extracted from C. elegans using TRIZOL Reagent
(Invitrogen, USA), and the cDNA of the target gene was ampliﬁed
by reverse transcriptase coupled PCR (RT-PCR) (AccessQuick
RT-PCR System, Promega) following the manufacturer’s instructions.
The primers were designed by introducing NdeI and BamHI restriction
enzyme sites as follows: 5 0-ggaattccatatggcaacaccggaaactcg-3 0 (the
underline indicates the NdeI site) and 5 0-cgggatcctcactgctccatggtgtgc-
3 0 (the underline indicates the BamHI site). The ampliﬁed cDNA frag-
ment was inserted into a pET28a vector. The positive clone was con-
ﬁrmed by PCR and DNA sequencing, followed by transformation
into Escherichia coli expression strain Rosetta (DE3). The expression,
solubility test and large-scale puriﬁcation of the recombinant protein
were performed by following the procedure from our previous study
[12].
2.2. Enzyme assays
Using the puriﬁed recombinant protein, enzymatic activity of ADLP
was measured following the method described previously [9]. The
nucleoside monophosphates and triphosphates were obtained from
Sigma. [c-32P]-ATP (5000 Ci/mmol) and [a-32P]-AMP (3000 Ci/mmol)
were obtained from Furui Company, China. A phosphoryltransfer as-
say was performed with [c-32P]-ATP as the phosphate donor and non-
radioactive nucleoside monophosphates (Sigma, USA) as substrates.
Each standard reaction mixture contains 50 mM Tris–HCl (pH 7.5),
5 mM DTT, 5 mM MgCl2, 2 mM NMP, 1 lCi/ll [c-
32P]-ATP and
50 ng of tested protein in a total volume of 50 ll. The reaction solution
was incubated at 37 C for 20 min, stopped by heating at 70 C for
2 min, and the sample was centrifuged at 3000 rpm for 10 s. The reac-
tion products were separated by thin-layer chromatography on poly-
ethyleneimine-cellulose F chromatography sheets (Merck, USA),
which were autoradiographed using a storage phosphor screen (Amer-
sham Biosciences, USA). A reaction mixture without ADLP was usedblished by Elsevier B.V. All rights reserved.
Fig. 1. Alignment of the amino acid sequences of ADLP (C.AK6) with NMPKs. The alignment was performed using the program Clustal X [31].
The sequences, identiﬁed using EMBL-EBI FASTA [32], are C. elegans AK1 (C.AK1), C. elegans AK6 (C.AK6), human AK1–6, human CMPK,
GMPK and TMPK in (A), and eukaryotic AK6 homologs from human (1RKBA), C. elegans (NP_496065), Drosophila (NP_610797) and
Arabidopsis (BAC42255) in (B). The asterisks and black boxes indicate the strictly conserved residues. Secondary structure elements are depicted
based on the human AK6 structure [9].
3812 R. Zhai et al. / FEBS Letters 580 (2006) 3811–3817as negative control to subtract the background; while a commercially
available AK1 (Sigma) was used as positive control. Screening of phos-
phate donor was performed with [a-32P]-AMP as substrate and non-
radioactive nucleoside triphosphate as phosphate donor following
the procedure described above.2.3. Green ﬂuorescent protein fusion protein
Both N-terminal and C-terminal green ﬂuorescent protein (GFP) fu-
sion ADLP proteins were constructed by using the following primers:
5 0-ccggaattcatgttgcttccgaacatcc-30 (the underline indicates the EcoRI
site) and 5 0-ccgggatccagagttatgatctttgatcc-30 (the underline indicates
R. Zhai et al. / FEBS Letters 580 (2006) 3811–3817 3813the BamHI site). HeLa cells were used to carry out transfection assays
as described previously [9], and visualized with a ﬂuorescent micro-
scope 24 hours after transfection. The nuclear dye 4,6-diamidino-2-
phenyl-indol-dihydrochloride (DAPI) (1 lg/ml in mowiol) was used
to stain DNA and visualize the nucleus.
2.4. RNA interference of ADLP by feeding in C. elegans
An RNA interference (RNAi) assay was performed as described by
Kamath [13] with the following minor modiﬁcation: the cDNA that
encodes ADLP was cloned into the L4440 feeding vector
(pPD129.36) [14] using PstI and BglII sites. The resulting plasmid
was transformed into E. coli strain HT115 (DE3), and the L4440 vec-
tor was used as negative control. Expression of the dsRNA was in-
duced overnight at room temperature. Two L4-stage worms were
placed onto each NGM plate, followed by incubation at 20 C for 2
days. The two L4-stage worms were re-picked, transferred onto new
sets of plates, and incubated at 20 C for 3 or 4 days for egg laying.
2.5. Real-time quantitative RT-PCR
The loss of the ADLP transcripts following RNAi was examined by
real-time quantitative RT-PCR. Total RNA samples, extracted from
RNAi-treated or control C. elegans, were reverse-transcribed as de-
scribed above. Real-time RT-PCR was performed with the SYBR
Green qPCR kit (Finnzymes) in a DNA Engine Opticon continuous
ﬂuorescence detection system (MJ Research) according to the manu-
facturer’s instructions. The expression level of the target gene in
RNAi-treated worms was compared with that of the non-treated
worms. To minimize mRNA quantiﬁcation errors and genomic
DNA contamination biases, and to correct for inter-sample variations,
we used the isocitrate dehydrogenase (IDH) gene (F35G12.2), a house-
keeping gene of C. elegans, as an internal control, and the relative
expression ratio was based on the expression of a target gene relative
to that of IDH. Primers used for detection of ADLP (Accession No.
NM_063664) transcripts were 5 0-tgtcgattatcacggatgt-30 and 5 0-tcatg-
gacgatgtcttcac-3 0, and those for IDH (Accession No. NM_065526)
were 5 0-gctttgaagggaaacattg-30 and 5 0-gattcgacaacacgaggat-30. Signiﬁ-
cance was determined with a T test (P < 0.05).
2.6. Western blotting
Antiserum against the recombinant protein was prepared by immu-
nizing a rabbit following a procedure described previously [9]. Western
blot analysis for ADLP was conducted on the protein extracts from
wild-type adult worms and RNAi-treated worms by using the anti-
ADLP. b-Actin was used as an internal control for normalizing the
loading materials. The proteins were extracted from worms with the ly-
sis buﬀer [50 mM Tris–HCl (pH 8.0), 300 mM NaCl, 1% NP-40, 1 mM
EDTA, 1 mM dithiothreitol (DTT), 1 mM phenylmethylsulfonyl ﬂuo-
ride (PMSF)] and electrophoresed on a 15% SDS–PAGE apparatus,
followed by transferal onto a nitrocellulose membrane using a wet
blotting device (Bio-Rad, USA). The membrane was incubated with
anti-ADLP (1:1000) or anti-b-Actin (1:500, Santa Cruz, CA, USA) pri-
mary antibodies, and subsequently incubated with anti-rabbit IgG-
HPR (1:500, Huamei Company, China) secondary antibody. The
membrane was developed in ECL chemiluminescence reagent (Pierce,
USA) and exposed to X-ray ﬁlm (Kodak, USA).A
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Fig. 2. Cloning, expression and puriﬁcation of ADLP in E. coli Rosetta (D
cDNA of ADLP obtained by RT-PCR examined on a 1.0% agarose gel. (B
ADLP in C. elegans examined by Western blot analysis by using the antiserum
was used as a positive control (lane 2).3. Results
3.1. Cloning and expression of ADLP in E. coli
The cDNA of ADLP was successfully obtained by RT-PCR,
which was consistent with its predicted length, 546 bp
(Fig. 2A), followed by insertion into vector pET28a, and ver-
iﬁcation by PCR analysis and DNA sequencing. An N-termi-
nal (His)6-tag was utilized, which is convenient for protein
puriﬁcation.
Optimization of the expression conditions showed that
ADLP was expressed well in Rosetta (DE3) at 30 C for
obtaining the maximum amount of soluble proteins. Puriﬁca-
tion of recombinant protein was performed in two steps using
a Ni-aﬃnity column and a Superdex-75 column. SDS–PAGE
analysis of the puriﬁed protein showed only one band at the
position corresponding to the predicted molecular weight
(Fig. 2B), which was also veriﬁed by Western blot with mono-
clonal His-tag antibody (data not shown). The concentration
of the puriﬁed protein was estimated with the Bio-Rad Protein
Assay Kit, and the results showed that about 10–15 mg recom-
binant protein can be obtained from 1 L culture with at least
95% purity.
An antiserum against ADLP was obtained by immunizing a
rabbit with the puriﬁed recombinant ADLP, and the internal
expression of ADLP in C. elegans was veriﬁed by Western blot
as shown in Fig. 2C.
3.2. ADLP shows the enzymatic activity of an adenylate kinase
First, a phosphoryltransfer assay with [c-32P]ATP as a phos-
phate donor was performed to evaluate the catalytic activity of
C. elegans ADLP, to see whether it possesses the activity of an
adenylate kinase. As shown in Fig. 3A, ADLP showed adenyl-
ate kinase activity.
Therefore, we performed the following experiments to fur-
ther characterize the detailed features of ADLP. Diﬀerent sub-
strates AMP, CMP, TMP, UMP, GMP, IMP, dAMP, dGMP,
dCMP, and dIMP were screened with the phosphate donor
ATP. A commercial AK1 from chicken (Sigma) was used as
positive control. According to the results obtained (Fig. 3B),
AMP and dAMP were the best phosphate acceptors of all
tested NMPs, CMP and TMP showed signiﬁcant activity,
dCMP can also be phosphorylated to some extent, while
IMP and UMP showed weak activity. Since there is structural
similarity between the AK family and bacterial shikimate ki-
nase [15], non-nucleotide substrate such as shikimate acid
was examined here with the result showing that shikimate acid35KD
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Fig. 3. Enzyme assays of ADLP by TLC blotting. (A) Enzymatic activity of ADLP as an AK. Lanes 1 and 2 showed the activity of a negative control
and ADLP, respectively. (B) Screening of substrate speciﬁcity of ADLP. Lane 1, negative control; lane 2, positive control (AK1); lanes 3–12 are the
nucleoside monophosphates AMP, CMP, TMP, GMP, UMP, IMP, dAMP, dCMP, dGMP, and dIMP, respectively. (C) ADLP can phosphorylate
the non-nucleotide substrate shikimate acid. (D) ADLP catalyzed phosphorylation of radiolabeled AMP with diﬀerent phosphate donors. Lane 1,
negative control; lane 2, positive control (AK1); lanes 3–10 are the nucleoside triphosphates ATP, CTP, TTP, UTP, GTP, ITP, dATP, and dGTP,
respectively.
Fig. 4. Subcellular localization of ADLP in HeLa cells via ﬂuorescence
microscopy. Cells were transfected with pEGFP-ADLP and visualized
with a ﬂuorescent microscope (left panel). DAPI staining of nuclear
DNA (right panel).
3814 R. Zhai et al. / FEBS Letters 580 (2006) 3811–3817could be phosphorylated in addition to the monophosphates
described above (Fig. 3C).
The preferred phosphate donors were examined by testing
ATP, GTP, CTP, UTP, TTP, ITP, dATP, and dGTP, using
[a-32P] AMP as substrate. The results showed that ATP was
the best phosphate donor, and dATP was a good phosphoryl
donor, while the others were poor donors in comparison to
ATP and dATP (Fig. 3D).
3.3. ADLP localized to the nucleus of HeLa cells
A potential nuclear localization motif rich in basic amino
acids at the N-terminus of ADLP, RRRPN, was identiﬁed
according to the predictive result of PSORT II [16] (Fig. 1).
To detect the subcellular localization of ADLP, we fused it
to GFP. Fig. 4 showed the ﬂuorescence microscopy of N-ter-
minal GFP fused ADLP, which localized to the nucleus, as
demonstrated by the staining of the nucleus with DAPI. Sim-
ilar results were observed from a C-terminal GFP fusion pro-
tein (data not shown).
3.4. RNAi in C. elegans
To investigate the eﬀects of RNAi on growth, worm size and
life span in detail, we have closely observed the worms’ devel-
opment at 20 C. Visible RNAi phenotype in RNAi-treated
plates was observed compared to control. Following exposure
to the corresponding dsRNA, compared to the control worms,
a slow growth (Gro) defect was induced in the F1 generation.
The size of worms in the plates treated with RNAi appears
smaller than those in control plates, although there is no diﬀer-
ence in conﬁguration and movement (Fig. 5A).
To conﬁrm that the observed slow growth of worms was due
to silencing of ADLP transcription following RNAi treatment,
we quantitatively determined the level of ADLP expression
through real-time RT-PCR and Western blot analysis in
RNAi-treated and wild-type worms. Fig. 5B showed themRNA level in the absence of ADLP cDNA from RNAi-trea-
ted worms was only about 38% of that of the control without
RNAi treatment, which indicated that the expression levels in
the RNAi treated worms were signiﬁcantly lower than those in
the controls (P < 0.05). The results of the Western blot analysis
showed that the expression level of the ADLP was signiﬁcantly
decreased in the RNAi-treated worms (Fig. 5C), in agreement
with the real-time RT-PCR result. These results indicated that
after RNAi treatment, the expression of ADLP was decreased
at both the mRNA and protein levels.4. Discussion
According to bioinformatics analysis by BLAST, ADLP
contains a conserved domain, the P-loop, indicating that this
protein has a functional correlation with ATP. In this study,
we utilized a phosphoryltransfer assay to conﬁrm that ADLP
does have NMPK enzyme activity. The substrate speciﬁcity
of ADLP is diﬀerent from all other AKs.
control RNAi+
A B C
Fig. 5. RNAi in C. elegans. (A) Morphological appearance of an RNAi treated worm. The right panel shows a worm after exposure to dsRNA for 4
days, and the left shows the control worm observed under the same resolution. (B) Relative mRNA expression level by RNAi. The graph represents
the relative diﬀerential mRNA expression ratio of ADLP (C.AK6) in the F1 generation of RNAi-ADLP-treated worms compared to control by real-
time RT-PCR analysis. Expression ratio was calculated as the ratio between the means of the steady-state mRNA levels of RNAi-treated and control
worms by the method of 2DDt [33]. Bars represented S.D.s calculated from four repeats of the experiment. *Signiﬁcance vs. control, P < 0.05. (C)
Western blot analysis showing the altered expression of ADLP in RNAi-treated worms. b-Actin was used as a quality control.
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same phosphate acceptors, AMP and to a lesser extent dAMP,
although their phosphate donors are largely diﬀerent: AK1
uses only ATP, but AK3 prefers GTP and ITP [8,17]. Addi-
tionally, AK2 uses ATP and AMP as its substrates [8,18],
AK4 has not been detected to possess any activity in vitro or
in vivo [17], and AK5 phosphorylates AMP and dAMP with
ATP as the phosphate donor, and AMP, CMP and dCMP
with GTP as the phosphate donor [4]. CTP and UTP are the
preferred phosphate donors for human AK6 and AMP,
dAMP, CMP, dCMP have demonstrated signiﬁcant activities
as substrates [9]. TMPK phosphorylates dTMP and dUMP
to their respective diphosphate forms; its best phosphate do-
nors are ATP, dATP, GTP, and dGTP, and it can also use sev-
eral other phosphate donors [19]. CMPK phosphorylates
CMP, dCMP, and UMP with highest eﬃciency using ATP
and dATP as the preferred donors, although it has several
other donors [20]. Guanylate kinase (GK) catalyzes the reac-
tions from GMP and dGMP to GDP and dGTP, respectively,
whose best donors are ATP, dATP, GTP, CTP, and UTP [21].
In the case of ADLP, it has three unique features compared
with other characterized adenylate kinases: (a) it only uses
ATP and dATP as phosphate donors, diﬀerent from other
AKs; (b) it can use a wide-range of nucleoside monophos-
phates as phosphate acceptors: the best phosphate acceptors
for ADLP are AMP and dAMP, CMP and TMP are also good
substrates, and dCMP is a substrate to a lesser extent; (c) be-
sides the nucleoside monophosphates described above, non-
nucleotide substrates such as shikimate acid can also be phos-
phorylated as the phosphate acceptor and show signiﬁcant
activity (Fig. 3C), diﬀerent from human AK6, in which no
activity was detected when using shikimate acid as substrate
[9]. Sequence analysis suggested that ADLP has more similar-
ities with shikimate kinase in shikimate-binding site than that
of human AK6 (Supplementary data). This is consistent with
the observation of shikimate kinase activity in ADLP but
not human AK6.
The previously characterized AKs showed diﬀerent subcellu-
lar locations. Both human AK6 and its homolog in yeast,
Fap7, are localized to the cell nucleus [9,22], which are diﬀerent
from that observed in other adenylate kinase isoforms [6,23].
AK1 localizes in the cytosol, and AK2 localizes in the mito-chondrial inter-membrane space [24], both AK3 and AK4
localize in the mitochondrial matrix [17,25,26], and AK5 was
found in both the cytosol and nucleus [4]. Our result for ADLP
from C. elegans showed that this protein was mainly localized
in the nucleus (Fig. 4), which is similar to that of human AK6.
The result of ADLP localization was consistent with that of
bioinformatics analysis. Both LOCtree [27] and LOCkey [28]
analysis suggest that ADLP indeed exists in the nucleus. Fur-
thermore, through PSORT II [16], a useful tool for nuclear
localization sequence (NLS) prediction, the N-terminal poly-
basic peptide RRRPN was identiﬁed as the NLS, and may ex-
plain why this protein is localized to the nucleus. Another pos-
sible explanation for this nuclear localization is that ADLP
may be co-transported into the nucleus by binding to other
proteins through the abundantly conserved acidic amino acids
presented on the surface of the protein, as proposed for human
AK6 [9]. Further experiments will be performed to investigate
the mechanism of ADLP transportation.
The results of subcellular localization (Fig. 4) and enzymatic
activity (Fig. 3), accompanied with the sequence alignment
(Fig. 1) and an unrooted radial phylogenetic tree (Fig. 6), indi-
cated that ADLP and human AK6 should be classiﬁed in the
same family even though their substrate speciﬁcities show
some diﬀerences. Therefore, we designate ADLP as C. elegans
AK6 (C.AK6).
Since C.AK6 protein is identiﬁed as one of the isoforms of
adenylate kinase which plays an important role in the synthesis
of nucleotides and is required for a variety of cellular meta-
bolic processes, knockdown of C.AK6 may have great eﬀect
on the growth or development of C. elegans. The result of an
RNAi experiment showed a Gro phenotype (Fig. 5A), and
the expression of C.AK6 was decreased at both transcriptional
and translational levels, suggesting that the interference of
C.AK6 may hold functions related to the growth of C. elegans.
This observation is similar to that obtained from AK2 of Dro-
sophila melanogaster and Fap7 of yeast [7,22]. Noma’s study
reported that in Drosophila, lack of the AK2 gene caused sig-
niﬁcant insect growth suppression, further experimentation
suggested that AK2 was essential for survival and had eﬀects
on rhythm formation [7]. In yeast, the point mutant fap7-1
was revealed to slow growth on glucose compared with the
wild type [22]. In addition, Wieringa’s group found that the
Fig. 6. An unrooted radial phylogenetic tree was constructed on the basis of sequence alignments of AK isoforms found in human and C. elegans,
including C. elegans AK1 (AAG50236) (C.AK1), C. elegans AK6 (NP_496065) (C.AK6), human AK1 (NP_000467), human AK2 (AAH09405),
human AK3 (BAA87913), human AK4 (P27144), human AK5 (Q9Y6K8), human AK6 (1RKBA), human CMPK (NP_057392), human GK
(NP_000849), and human TMPK (NP_036277).
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to support muscle energy metabolism [29]. So the question
concerning C.AK6 was raised: What is the mechanism of
C.AK6 in worm growth? The result of a recent report about
human AK6 (H.AK6) showed that hCINAP (H.AK6) can
interact with collin, a marker protein of Cajal bodies [30].
Additionally, it is well known that Cajal bodies are involved
in nuclear splicing. Since C.AK6 was found to localize to the
cell nucleus, whether the slow growth of the worm resulting
from RNAi knockdown of C.AK6 is due to disturbance of
RNA splicing in nucleus or related events will be an interesting
question to investigate.
Thus far, six AK isozymes, AK1–6 were identiﬁed that con-
tribute to the homeostasis of cellular adenine nucleotide com-
position and nucleotide biosynthesis. The information
obtained so far indicated the function of AK is associated with
the mechanism of eﬃcient transfer of high-energy phosphate in
micro-compartments within the cell [7]. However, more eﬀort
is needed to unravel the real biological roles that AKs serve.
The enzymatic characterization and phenotypic analysis of
C.AK6, together with the characterization of other NMPKs,
will help us to address these questions not only to illustrate
the roles of adenylate kinases in energy metabolism but also
link them to large-scale cellular phenomena such as signal
transduction and the regulation of cell proliferation.
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